Remove keyword guidance
article thumbnail

Overview of FDA Expedited Development and Approval Programs for Serious Conditions

Impact Pharmaceutical Services

In May of 2014 and February of 2019 , the FDA released final Guidance for Industry outlining the Agency’s policies and procedures regarding expedited development and review programs for new drugs and biologics intended to treat serious or life-threatening conditions. Image courtesy of qimono at pixabay.com.

FDA 52
article thumbnail

ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma

ISPE

Case 1: Creating Paragraphs from a Set of Keywords Authors: “Please provide a section about data integrity in computerized systems from a pharma quality assurance perspective in 100 words.” The Keyword. ChatGPT : “Data integrity in computerized systems is critical for ensuring the quality and safety of pharmaceutical products.